RT @iexp_paciente: El coste para desarrollar medicamentos nuevos ha aumentado un 145% desde 2013. La #experienciadepaciente es la clave de…
El coste para desarrollar medicamentos nuevos ha aumentado un 145% desde 2013. La #experienciadepaciente es la clave de un ensayo clínico e involucrar a los #pacientes reduce el coste del mismo. Por ello, es fundamental conocer la opinión los pacientes. ht
RT @PaulLikeMe: @bsw5020 On that altruism point - here is how ALS patients compare to other chronic diseases - https://t.co/ziNBUZidQc
RT @PaulLikeMe: @bsw5020 On that altruism point - here is how ALS patients compare to other chronic diseases - https://t.co/ziNBUZidQc
@bsw5020 On that altruism point - here is how ALS patients compare to other chronic diseases - https://t.co/ziNBUZidQc
"Most patients are willing to enroll yet very few are invited. When they do, trial participation is often burdensome, but patients are willing to help improve their design..." https://t.co/DKNovr7SxS
RT @BioNagoya: PatientsLikeMe: Clinical trials from the patient perspective: survey in an online patient community https://t.co/CNmr1ugruh
RT @PaulLikeMe: .@SpencerPHey enjoyed your piece! Check out https://t.co/kKiTAqLWDT and https://t.co/ziNBUZzOHK, cheers! PW
.@SpencerPHey enjoyed your piece! Check out https://t.co/kKiTAqLWDT and https://t.co/ziNBUZzOHK, cheers! PW
Clinical trials from the patient perspective: survey in online patient community https://t.co/iJKX2lmuxj #clinicaltrials few are invited